Heidelberg Pharma AG
Common Stock · EUR · XETRA
Price
€2.7
Cap
€72.96M
Earnings
—
30d Trend
-4.6%
37% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 32×Macro 0.99 (−1%)=32
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Heidelberg Pharma AG at 32/100 — a WEAK reading on the Brain47 Signal. The strongest factor is quality at 51/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
-3.2%
3 MONTHS
-10.6%
12 MONTHS
-24.9%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Quality (51) and Technical (40) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is moderate at 37%. I classify this as a speculative position — risk characteristics and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.